TrialProstate cancer and prostatic diseases2021

Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancer.

Daniel E Lage et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.